Rafael Holdings Insider Selling Signals Rebalancing, Not Red Flag – Focus on ADC Oncology Growth
Rafael Holdings insider sales: CFO sells shares, but oncology pipeline shows strong Phase II ADC results and FDA Fast‑Track & Breakthrough designations, signaling growth potential.
3 minutes to read